Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
CRVO
$2.34
+2.18%
CRVO
· CervoMed Inc.
$2.34
+0.05 (+2.18%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 7, 2026
The latest filing no longer states the doubt (first flagged May 15, 2026).
View the 10-Q filed Aug 7, 2026Market Cap
$35.38M
Shares
15.12M
Volume · Oct 21
78.55K
Avg daily vol (3M)
284.59K
All webcasts
Earnings call · FY2020 Q2
CervoMed Inc. (CRVO) Q2 2020 Earnings Call
Diluted EPS
$3898371450.00
+1219% YoY
Net income
-$3.13M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 10, 2020 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 7, 2020 · complete as-filed document